# Inha University Hospital

Organization · id `cardio:org-inha-university-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 04gj5px28](<https://ror.org/04gj5px28>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 04gj5px28 by an exact name.

## The registry's words

- Sponsor name: Inha University Hospital
- Sponsor class: OTHER
- ROR name: Inha University Hospital

## Connected pages

- Sponsors: A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension (`cardio:ct-nct01518998`)
- Sponsors: Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent (`cardio:ct-nct01826552`)
- Sponsors: Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease (`cardio:ct-nct01932203`)
- Sponsors: FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease (`cardio:ct-nct02715518`)
- Sponsors: Dronedarone Rhythm Intervention for Early Atrial Fibrillation (`cardio:ct-nct07270848`)
- Sponsors: Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy (`cardio:ct-nct07796217`)

## Provenance

Content hash: 0b46a6a35290e5917a1469e62f8a3726d67339ea05bc3981eb944e157217e9e3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
